When choosing an export market for your MedTech product, are you basing your sales forecast on evidence or assumptions?

When you're a clinician founder looking to commercialise your MedTech product in export markets, identifying a large market can make your sales forecasts look incredibly attractive. After all, capturing just 1% of a £100 million market would generate £1 million in revenue. But market size doesn't tell you who will buy your medical device, why they'll choose it, how you'll reach them or how long it will take to generate those sales. In this episode, Hakeem explores why relying on market share assumptions can lead clinician founders to overestimate their commercial potential and what it takes to build a more credible export sales forecast.

In this episode you'll discover:

• Why assuming you can capture just 1% of a large export market doesn't necessarily mean your MedTech sales forecast is commercially achievable.
• How clinician founders can look beyond market size to understand the customers, competition, purchasing decisions and commercial barriers that influence their ability to generate sales.
• How working backwards from your revenue targets to customer numbers, purchasing behaviour, conversion rates and sales cycles can help you build a more realistic MedTech export commercialisation strategy.

Listen now to discover how to move beyond market share assumptions and build a more credible MedTech export sales forecast based on the customers you can realistically reach, convert and retain.

Book a 30min Healthcare Export Accelerator discovery call

Connect with me on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.